ADVM

Adverum Biotechnologies, Inc.

—

No price data yet — the yfinance scanner hasn't produced bars for ADVM.

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Other	2025-12-10	Seyedkazemi Setareh	CHIEF DEVELOPMENT OFFICER	—Direct	88,332	—	—
Grant	2025-12-10	Seyedkazemi Setareh	CHIEF DEVELOPMENT OFFICER	—Direct	85,000	—	—
Other	2025-12-10	Seyedkazemi Setareh	CHIEF DEVELOPMENT OFFICER	—Direct	8,125	—	—
Other	2025-12-10	Seyedkazemi Setareh	CHIEF DEVELOPMENT OFFICER	—Direct	54,874	—	—
Other	2025-12-10	Ozden Rabia Gurses	Chief Medical Officer	—Direct	85,000	—	—

Other

Seyedkazemi Setareh

CHIEF DEVELOPMENT OFFICER · 2025-12-10

—

88,332 shares

Grant

Seyedkazemi Setareh

CHIEF DEVELOPMENT OFFICER · 2025-12-10

—

85,000 shares

Other

Seyedkazemi Setareh

CHIEF DEVELOPMENT OFFICER · 2025-12-10

—

8,125 shares

Other

Seyedkazemi Setareh

CHIEF DEVELOPMENT OFFICER · 2025-12-10

—

54,874 shares

Other

Ozden Rabia Gurses

Chief Medical Officer · 2025-12-10

—

85,000 shares

28 more transactions on ProFull insider transaction history is a Pro feature.